Auther / Researcher : RMf_47867
  • Category : Healthcare
  • Region : Global
  • Publishing Date : 03/01/2020
Single User License $3000 Global User License $4000 Raise a query Download Sample

Global Clinical Trial Supplies Market- By Phase (l, ll, lll, and lV), By Drug Type (Small Molecule Drugs, Biologic Drugs), By Service (Manufacturing, Packaging & Logistics, Distribution, Storage, and Solutions), By Therapeutic Area (Oncology, Digestive System Diseases, Neurological & Mental Disorders, Blood Disorders, and Others) and By Region - Industry Analysis & Forecast to 2024


The global clinical trial supplies market is anticipated to reach USD 3.2 billion by 2025 at a CAGR of 7.5%.

This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global clinical trial supplies market. The historic years considered for the study are 2015-2017, base year is 2018, estimated year is 2019, and forecast period is 2019-2024.

The major players are Thermo Fisher Scientific, Inc. (US), PCI Services (US), Parexel International Corporation (US), Biocair (UK), O&M Movianto (US), Sharp Packaging Services (US), Catalent, Inc. (US), KLIFO A/S (Denmark), Bilcare Limited (India) and Alamc Group (UK).

​

Market definition

Clinical trial supplies market include products and services that make the clinical trials management more effective and efficient. Clinical trials are research studies to find out whether a new drug, vaccine, medical treatment & strategy, medical devices or dietary supplements are safe, and effective for humans. These are complex activities performed on human participants. A safe and secured clinical trial requires a strong supply chain management. The optimization of clinical trial supplies is the most vital part of any clinical trial. It helps to deliver the drug or the material that is to be studied, to the participants on time. The clinical trial supply chain includes manufacturing, packaging, storage & distribution, and temperature management of the investigational material. Clinical trials are performed in four phases, namely Phase I, Phase II, Phase III, and Phase IV.

 

Market Drivers

  • Growing Prevalence Of Chronic Diseases

  • Growing Need of Detection Level of Toxicity of the Drug at the Early Stages

  • Increasing Expenditure on R & D in Biopharmaceutical And Pharmaceutical Sector

  • Globalization of Clinical Trials

  • Outsourcing of Clinical Trials due to Harmonization of Regulations across the Globe

 

Market Restraints

  • High Cost of Clinical Trials and Drug Development

​

Market Opportunities

  • Growth in Biologics

  • Emerging market

  • Patent Expiration

​

Geographical Analysis

North America region contributed to the major market share of the global clinical supplies market. It is expected to continue dominance in the market during the forecast period, owing to the presence of contract research organisations in the region, increasing investments in R & D by pharmaceutical and biopharmaceutical companies. Asia-Pacific region is anticipated to grow at the highest growth rate during the forecast period, owing to huge number of patients coupled with less strict patient recruitment regulations.

​

Critical Questions Answered in the report

  • What are the key trends in the global clinical trial supplies market?

  • How the market (and its various sub segments) has grown in last four years and what would be the growth rate in next five years?

  • What are the key strategies adopted by the major vendors to lead the global clinical trial supplies market?

  • What is the market share of the top vendors?


Our research methodology consists of both primary and secondary research, wherein primary research data comprises of 85% and secondary research data comprises of 15%. It involved the extensive secondary sources such as annual reports of the leading healthcare manufacturers, healthcare associations and the leading healthcare industry associations. The research also involved the usage of paid databases such as Bloomberg, Factiva, Hoovers, and many others, in order to collect information useful for a technical and market-oriented study of the clinical trial supplies market. The primary sources mainly includes industry experts from healthcare industries and preferred suppliers, healthcare manufacturers, technologists, certified organizations, healthcare associations and organizations related to all segments of this value chain. Primary interviews were organized and conducted with various primary respondents of this industry. These includes subject matter experts (SMEs), healthcare industry participants, industry consultants, and executives of leading companies. We conduct in-depth interviews with these people in order to gain meaningful qualitative and quantitative information and also analyze the future prospects.

Primary Research
The clinical trial supplies market involves the various stakeholders in the whole supply chain such as equipment suppliers and end-use manufacturers. The extensive primary research was conducted in order to gain a meaningful insights about the market and industry growth. For the clinical trial supplies report, we have conducted primary surveys with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major manufacturers active in the healthcare industry. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next five years.

Secondary Research
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global clinical trial supplies market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, geographic markets, and developments related to the market and technology. We have gone through various credible sources such as annual reports, journals, white papers, SEC filings, company websites, and paid databases.


1 Executive Summary

 

2 Market Introduction

2.1 Definition

2.2 Architecture

2.3 Scope of the Study

2.4 Related Stakeholders

 

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.2.1 Key Insights

3.2.2 Breakdown of Primary Interviews

3.3 Secondary Research

3.3.1 Important Sources

3.4 Market Size Estimation Approaches

3.4.1 Top-Down Approach

3.4.2 Bottom-Up Approach

3.4.3 Data Triangulation

3.5 List of Assumptions

 

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Growing Prevalence Of Chronic Diseases

4.2.2 Growing Need of Detection Level of Toxicity of the Drug at the Early Stages

4.2.3 Increasing Expenditure on R & D in Bio-pharmaceutical And Pharmaceutical Sector

4.2.4 Globalization of Clinical Trials

4.2.5 Outsourcing of Clinical Trials due to Harmonization of Regulations across the Globe

4.3 Restraints

4.3.1 High Cost of Clinical Trials and Drug Development

4.4 Opportunities

4.4.1 Growth in Biologics

4.4.2 Emerging Market

4.4.3 Patent Expiration

4.5 Porter's Five Forces Model Analysis

4.6 Value Chain Analysis

4.7 Regulatory Landscape

​

5 Global Clinical Trial Supplies Market, By Products & Services

5.1 Introduction

5.2 Manufacturing

5.3 Packaging & Logistics

5.4 Distribution

5.5 Storage

5.6 Solutions

 

6 Global Clinical Trial Supplies Market, By Phase

6.1 Introduction

6.2 Phase I

6.3 Phase II

6.4 Phase III

6.5 Phase IV

 

7 Global Clinical Trial Supplies Market, By Therapeutic Area

7.1 Introduction

7.2 Oncology

7.3 Neurological and Mental Disorders

7.4 Infectious and Immune System Diseases

7.5 Digestive System Diseases

7.6 Blood Disorders

7.7 Others

 ​

8 Global Clinical Trial Supplies Market, By Drug Type

8.1 Introduction

8.2 Small Molecules

8.3 Biologics

 

9 Global Clinical Trial Supplies Market, By Region

9.1 Introduction

9.2 North America

9.2.1 US

9.2.2 Canada

9.2.3 Mexico

9.3 Europe

9.3.1 Germany

9.3.2 UK

9.3.3 France

9.3.4 Italy

9.3.5 Spain

9.3.6 Rest of Europe

9.4 Asia-Pacific

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 Rest of Asia-Pacific

9.5 Middle East and Africa

9.5.1 UAE

9.5.2 South Africa

9.5.3 Saudi Arabia

9.5.4 Rest of the Middle East and Africa

9.6 South America

9.6.1 Argentina

9.6.2 Brazil

9.6.3 Rest of the South America

 ​

10 Competitive Landscape

10.1 Introduction

10.2 Vendor Evaluation Criteria

10.3 Vendor Share Analysis, 2019

10.4 Recent Developments, 2016 -2019

10.4.1 New Product/Service Launches

10.4.2 Partnerships

10.4.3 Mergers or Acquisitions

10.4.4 Business Expansions

 

11 Company Profiles

(This section covers the Business Overview, Financial Overview, Product/Service Offerings, Recent Developments, SWOT Analysis, and Key Strategies of the top market vendors. The given sequence does not represent their rankings in the market.)

11.1   Thermo Fisher Scientific, Inc.(US)

11.2   PCI Services

11.3   Parexel International Corporation (US)

11.4   Biocair (UK)

11.5   O&M Movianto (US)

11.6   Sharp Packaging Services (US)

11.7   Catalent, Inc. (US)

11.8   KLIFO A/S (Denmark)

11.9   Bilcare Limited (India)

11.10 Alamc Group (UK)

 

12 Appendix

12.1 Discussion Guide

12.2 Customization Options

12.3 Related Reports

 

List of Tables

Table 1 Global Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 2 Global Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 3 Global Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 4 Global Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 5 Global Clinical Trial Supplies Market, By Region, 2015-2024 (USD Million)

Table 6 North America Clinical Trial Supplies Market, By Country, 2015-2024 (USD Million)

Table 7 North America Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 8 North America Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 9 North America Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 10 North America Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 11 US Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 12 US Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 13 US Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 14 US Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 15 Canada Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 16 Canada Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 17 Canada Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 18 Canada Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 19 Mexico Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 20 Mexico Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 21 Mexico Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 22 Mexico Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 23 Europe Clinical Trial Supplies Market, By Country, 2015-2024 (USD Million)

Table 24 Europe Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 25 Europe Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 26 Europe Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 27 Europe Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 28 Germany Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 29 Germany Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 30 Germany Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 31 Germany Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 32 UK Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 33 UK Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 34 UK Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 35 UK Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 36 France Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 37 France Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 38 France Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 39 France Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 40 Italy Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 41 Italy Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 42 Italy Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 43 Italy Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 44 Spain Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 45 Spain Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 46 Spain Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 47 Spain Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 48 Rest of Europe Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 49 Rest of Europe Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 50 Rest of Europe Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 51 Rest of Europe Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 52 Asia-Pacific Clinical Trial Supplies Market, By Country, 2015-2024 (USD Million)

Table 53 Asia-Pacific Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 54 Asia-Pacific Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 55 Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 56 Asia-Pacific Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 57 China Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 58 China Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 59 China Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 60 China Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 61 India Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 62 India Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 63 India Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 64 India Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 65 Japan Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 66 Japan Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 67 Japan Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 68 Japan Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 69 South Korea Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 70 South Korea Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 71 South Korea Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 72 South Korea Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 73 Rest of Asia-Pacific Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 74 Rest of Asia-Pacific Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 75 Rest of Asia-Pacific Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 76 Rest of Asia-Pacific Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 77 Middle East and Africa Clinical Trial Supplies Market, By Country, 2015-2024 (USD Million)

Table 78 Middle East and Africa Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 79 Middle East and Africa Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 80 Middle East and Africa Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 81 Middle East and Africa Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD

Table 82 South America Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 83 South America Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 84 South America Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 85 South America Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 86 Brazil Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 87 Brazil Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 88 Brazil Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 89 Brazil Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

Table 90 Rest of the South America Clinical Trial Supplies Market, By Service, 2015-2024 (USD Million)

Table 91 Rest of the South America Clinical Trial Supplies Market, By Phase, 2015-2024 (USD Million)

Table 92 Rest of the South America Clinical Trial Supplies Market, By Therapeutic Area, 2015-2024 (USD Million)

Table 93 Rest of the South America Clinical Trial Supplies Market, By Drug Type, 2015-2024 (USD Million)

 

List of Figures

Figure 1 Global Clinical Trial Supplies Market: Market Segmentation

Figure 2 Global Clinical Trial Supplies Market: Research Methodology

Figure 3 Breakdown of Primary Interviews

Figure 4 Top Down Approach

Figure 5 Bottom Up Approach

Figure 6 Data Triangulation

Figure 7 Global Clinical Trial Supplies Market: Drivers, Restraints, Opportunities, and Challenges

Figure 8 Global Clinical Trial Supplies Market: Porter's Five Forces Model Analysis

Figure 9 Global Clinical Trial Supplies Market: Value Chain Analysis

Figure 10 Global Clinical Trial Supplies Market Share Analysis, By Service, 2019 & 2024

Figure 11 Global Clinical Trial Supplies Market Share Analysis, By Phase, 2019 & 2024

Figure 12 Global Clinical Trial Supplies Market Share Analysis, By Therapeutic Area, 2019 & 2024

Figure 13 Global Clinical Trial Supplies Market Share Analysis, By Drug Type, 2019 & 2024

Figure 14 Global Clinical Trial Supplies Market Share Analysis, By Region, 2019 & 2024

Figure 15 North America Clinical Trial Supplies Market Share Analysis, By Country, 2019 & 2024

Figure 16 North America Clinical Trial Supplies Market Share Analysis, By Service, 2019 & 2024

Figure 17 North America Clinical Trial Supplies Market Share Analysis, By Phase, 2019 & 2024

Figure 18 North America Clinical Trial Supplies Market Share Analysis, By Therapeutic Area, 2019 & 2024

Figure 19 North America Clinical Trial Supplies Market Share Analysis, By Drug Type, 2019 & 2024

Figure 20 Europe Clinical Trial Supplies Market Share Analysis, By Country, 2019 & 2024

Figure 21 Europe Clinical Trial Supplies Market Share Analysis, By Service, 2019 & 2024

Figure 22 Europe Clinical Trial Supplies Market Share Analysis, By Phase, 2019 & 2024

Figure 23 Europe Clinical Trial Supplies Market Share Analysis, By Therapeutic Area, 2019 & 2024

Figure 24 Europe Clinical Trial Supplies Market Share Analysis, By Drug Type, 2019 & 2024

Figure 25 Asia-Pacific Clinical Trial Supplies Market Share Analysis, By Country, 2019 & 2024

Figure 26 Asia-Pacific Clinical Trial Supplies Market Share Analysis, By Service, 2019 & 2024

Figure 27 Asia-Pacific Clinical Trial Supplies Market Share Analysis, By Phase, 2019 & 2024

Figure 28 Asia-Pacific Clinical Trial Supplies Market Share Analysis, By Therapeutic Area, 2019 & 2024

Figure 29 Asia-Pacific Clinical Trial Supplies Market Share Analysis, By Drug Type, 2019 & 2024

Figure 30 Middle East & Africa Clinical Trial Supplies Market Share Analysis, By Country, 2019 & 2024

Figure 31 Middle East & Africa Clinical Trial Supplies Market Share Analysis, By Service, 2019 & 2024

Figure 32 Middle East & Africa Clinical Trial Supplies Market Share Analysis, By Phase, 2019 & 2024

Figure 33 Middle East & Africa Clinical Trial Supplies Market Share Analysis, By Therapeutic Area, 2019 & 2024

Figure 34 Middle East & Africa Clinical Trial Supplies Market Share Analysis, By Drug Type, 2019 & 2024

Figure 35 South America Clinical Trial Supplies Market Share Analysis, By Country, 2019 & 2024

Figure 36 South America Clinical Trial Supplies Market Share Analysis, By Service, 2019 & 2024

Figure 37 South America Clinical Trial Supplies Market Share Analysis, By Phase, 2019 & 2024

Figure 38 South America Clinical Trial Supplies Market Share Analysis, By Therapeutic Area, 2019 & 2024

Figure 39 South America Clinical Trial Supplies Market Share Analysis, By Drug Type, 2019 & 2024